Sernova Biotherapeutics (SEOVF) Projected to Post Earnings on Thursday

Sernova Biotherapeutics (OTCMKTS:SEOVF) is anticipated to issue its resultson Thursday, June 11th. Analysts expect the company to announce earnings of ($0.0074) per share for the quarter.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last posted its quarterly earnings data on Thursday, March 19th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01).

Sernova Biotherapeutics Trading Up 2.4%

Shares of OTCMKTS SEOVF opened at $0.12 on Thursday. Sernova Biotherapeutics has a 1-year low of $0.09 and a 1-year high of $0.16. The company has a 50-day moving average of $0.12 and a two-hundred day moving average of $0.11. The company has a market cap of $44.49 million, a PE ratio of -2.95 and a beta of 0.82.

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.